These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6097208)

  • 1. Treatment of hypertension with angiotensin converting enzyme inhibitors.
    Johnston CI
    Aust N Z J Med; 1984 Aug; 14(4):509-13. PubMed ID: 6097208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors: past, present, and bright future.
    Edwards CR; Padfield PL
    Lancet; 1985 Jan; 1(8419):30-4. PubMed ID: 2856956
    [No Abstract]   [Full Text] [Related]  

  • 3. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
    Lindsjö M; Danielson BG; Weiss L; Wikström B
    Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J
    Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
    [No Abstract]   [Full Text] [Related]  

  • 5. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
    Bauer JH
    Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
    Smith CD; Smith RD; Korn JH
    Arthritis Rheum; 1984 Jul; 27(7):826-8. PubMed ID: 6331462
    [No Abstract]   [Full Text] [Related]  

  • 12. Converting enzyme inhibitors in hemodialysis.
    Bazilinski N
    Int J Artif Organs; 1983 Mar; 6(2):62-4. PubMed ID: 6302010
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
    Riley LJ; Vlasses PH; Ferguson RK
    Am Heart J; 1985 May; 109(5 Pt 1):1085-9. PubMed ID: 2986440
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of captopril-induced rash after substitution of enalapril.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Pharmacotherapy; 1983; 3(2 Pt 1):131-3. PubMed ID: 6304662
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Johnston CI; Arnolda L; Hiwatari M
    Drugs; 1984 Mar; 27(3):271-7. PubMed ID: 6323123
    [No Abstract]   [Full Text] [Related]  

  • 17. Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
    Materson BJ
    Am J Med; 1984 Oct; 77(4A):128-34. PubMed ID: 6207725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.
    Van Zwieten PA; De Jonge A; Timmermans PB
    Pharm Weekbl Sci; 1983 Oct; 5(5):197-204. PubMed ID: 6316248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.